At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 179 enrolled
Drug / intervention
400 IU Vitamin D3 +1 moredrug
Likely dose
400 IU Vitamin D3from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Antenatal Vitamin D3 Supplementation on Risk of Pre-eclampsia
In Brief
A Phase 2 clinical trial evaluating 400 IU Vitamin D3 and 4000 IU Vitamin D3 for Vitamin D Deficiency and Pre-Eclampsia. Completed, enrolled 179 participants.
Detailed Summary
Vitamin D deficient pregnant ladies were selected and randomized into 2 groups for routine daily dose of multivitamin (400IU vitamin D3) versus maximum safest treatment daily dose (4000IU vitamin D3). Participants were assessed and compared for number of pre-eclampsia cases.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVitamin D Deficiency, Pre-Eclampsia
Countries--
Collaborators--
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2012
Primary CompletionOct 2014
Study CompletionDec 2015
First PostedApr 2017
TodayJul 2026
First PostedApr 4, 2017
Enrollment StartOct 1, 2012
Primary CompletionOct 31, 2014
Study CompletionDec 31, 2015
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 9.2 years ago
Interventions
400 IU Vitamin D3drug
Antenatal multivitamin
4000 IU Vitamin D3drug
4000 IU Vitamin D3 (cholecalciferol) daily = 40 drops daily